Valuation: GENFIT

Market Cap 721M 842M 675M 618M 1.16B 80.57B 1.17B 7.97B 3.11B 40.48B 3.16B 3.09B 134B P/E 2026 *
37.2x
P/E 2027 * 95.8x
Enterprise Value 670M 782M 627M 574M 1.08B 74.86B 1.09B 7.41B 2.89B 37.61B 2.94B 2.87B 124B EV / Sales 2026 *
6.69x
EV / Sales 2027 * 5.28x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day+2.27%
1 week+10.75%
Current month-1.64%
1 month+9.08%
3 months+69.25%
6 months+82.99%
Current year+173.88%
1 week 13.2
Extreme 13.2
14.82
1 month 12.74
Extreme 12.74
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/7/23 Buy

Director

5,300 0.0106%
7/7/23 Buy

Chief Executive Officer

10,000 0.0201%
7/7/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%+10.75%+280.88%+355.61% 842M
+1.09%+5.26%+4.52%+26.24% 51.61B
-1.07%+2.82%+465.96%+586.75% 44.89B
+1.47%+9.79%+35.92%+21.40% 42.77B
+1.44%+7.77%+19.38%+92.75% 42.58B
-0.93%-4.33%+16.18%+53.76% 31.82B
+1.32%+7.30%+33.89%+150.10% 17.33B
-0.60%+1.93% - - 16.63B
+0.03%+3.41%+6.55%+32.10% 14.76B
+1.28%+5.41%+82.40%+47.43% 14.09B
Average +0.63%+5.07%+105.07%+151.79% 27.73B
Weighted average by Cap. +0.49%+4.74%+100.16%+146.97%

Financials

2026 *2027 *
Net sales 100M 117M 93.75M 85.82M 161M 11.19B 163M 1.11B 432M 5.62B 439M 430M 18.6B 124M 145M 116M 106M 199M 13.86B 202M 1.37B 535M 6.96B 544M 532M 23.02B
Net income 22.88M 26.71M 21.41M 19.6M 36.77M 2.56B 37.26M 253M 98.63M 1.28B 100M 98.1M 4.25B 6.8M 7.94M 6.36M 5.82M 10.93M 760M 11.07M 75.17M 29.31M 382M 29.81M 29.16M 1.26B
Net Debt -51.12M -59.67M -47.83M -43.78M -82.17M -5.71B -83.25M -565M -220M -2.87B -224M -219M -9.49B -66.17M -77.25M -61.92M -56.68M -106M -7.39B -108M -732M -285M -3.71B -290M -284M -12.28B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
21/08/26 EUR 14.42 +2.27% 206,111
20/08/26 EUR 14.10 -2.08% 307,015
19/08/26 EUR 14.40 +4.96% 410,201
18/08/26 EUR 13.72 -1.15% 203,967
17/08/26 EUR 13.88 +6.61% 404,952
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.42EUR
Average target price
15.90EUR
Spread / Average Target
+10.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock